MUC1 Initiates Src-CrkL-Rac1/Cdc42–Mediated Actin Cytoskeletal Protrusive Motility after Ligating Intercellular Adhesion Molecule-1

MUC1, a transmembrane glycoprotein of the mucin family, when aberrantly expressed on breast cancer cells is correlated with increased lymph node metastases. We have previously shown that MUC1 binds intercellular adhesion molecule-1 (ICAM-1) on surrounding accessory cells and facilitates transendothelial migration of MUC1-bearing cells. Nevertheless, the underlying molecular mechanism is still obscure. In the present study, we used a novel assay of actin cytoskeletal reorganization to show that by ligating ICAM-1, MUC1 triggers Rac1- and Cdc42-dependent actin cytoskeletal protrusive activity preferentially at the heterotypic cell-cell contact sites. Further, we show that these MUC1/ICAM-1 interaction–initiated lamellipodial and filopodial protrusions require Src family kinase and CT10 regulator of kinase like (CrkL) accompanied by the rapid formation of a Src-CrkL signaling complex at the MUC1 cytoplasmic domain. Through inhibition of Src kinase activity, we further revealed that Src is required for recruiting CrkL to the MUC1 cytoplasmic domain as well as mediating the observed actin cytoskeleton dynamics. These findings suggest a novel MUC1-Src-CrkL-Rac1/Cdc42 signaling cascade following ICAM-1 ligation, through which MUC1 regulates cytoskeletal reorganization and directed cell motility during cell migration. (Mol Cancer Res 2008;6(4):555–67)

[1]  P. Singh,et al.  Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. , 2007, Cancer research.

[2]  A. Nobel,et al.  Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .

[3]  S. Gendler,et al.  Tyrosines in the MUC1 Cytoplasmic Tail Modulate Transcription via the Extracellular Signal-Regulated Kinase 1/2 and Nuclear Factor-κB Pathways , 2006, Molecular Cancer Research.

[4]  L. Pham,et al.  Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas , 2006 .

[5]  Michael D Schaller,et al.  The interplay between Src and integrins in normal and tumor biology , 2004, Oncogene.

[6]  J. Hugh,et al.  MUC1 Initiates a Calcium Signal after Ligation by Intercellular Adhesion Molecule-1* , 2004, Journal of Biological Chemistry.

[7]  D. Kufe,et al.  The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 Fibroblasts* , 2004, Journal of Biological Chemistry.

[8]  E. Lillehoj,et al.  Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail. , 2003, Biochemical and biophysical research communications.

[9]  K. Pienta,et al.  Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. , 2003, Cancer research.

[10]  M. Okura,et al.  Translocation of CrkL to Focal Adhesions Mediates Integrin-Induced Migration Downstream of Src Family Kinases , 2003, Molecular and Cellular Biology.

[11]  S. Gendler,et al.  MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion , 2003, Oncogene.

[12]  K. Nagashima,et al.  DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines. , 2002, Blood.

[13]  Stefano Iacobelli,et al.  The mechanism involved in the regulation of phospholipase Cγ1 activity in cell migration , 2002, Oncogene.

[14]  D. Kufe,et al.  Protein Kinase C δ Regulates Function of the DF3/MUC1 Carcinoma Antigen in β-Catenin Signaling* , 2002, The Journal of Biological Chemistry.

[15]  R. Favaloro,et al.  Tyrosine Kinase c-Src Constitutes a Bridge between Cystic Fibrosis Transmembrane Regulator Channel Failure and MUC1 Overexpression in Cystic Fibrosis* , 2002, The Journal of Biological Chemistry.

[16]  J. Feldner,et al.  Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization. , 2002, Experimental cell research.

[17]  L. Yin,et al.  The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-Catenin* , 2001, The Journal of Biological Chemistry.

[18]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Pasdar,et al.  The importance of MUC1 cellular localization in patients with breast carcinoma , 2001, Cancer.

[20]  S. Gendler,et al.  Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland* , 2001, The Journal of Biological Chemistry.

[21]  D. Kufe,et al.  The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3β and β-Catenin* , 2001, The Journal of Biological Chemistry.

[22]  F. Itoh,et al.  New Aspects and Mucosal Repair , 2001 .

[23]  K. Rottner,et al.  Interplay between Rac and Rho in the control of substrate contact dynamics , 1999, Current Biology.

[24]  Alan Hall,et al.  Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement , 1999, The Journal of cell biology.

[25]  J. Hugh,et al.  MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. , 1998, Cancer research.

[26]  M. Matsuda,et al.  Activation of Rac1 by a Crk SH3-binding protein, DOCK180. , 1998, Genes & development.

[27]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[28]  David Cowburn,et al.  Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G , 1998, Oncogene.

[29]  Simon C Watkins,et al.  Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. , 1998, Journal of immunology.

[30]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[31]  L. Van Aelst,et al.  Rho GTPases and signaling networks. , 1997, Genes & development.

[32]  K. Furuya,et al.  Temperature dependency of calcium responses in mammary tumour cells , 1997, Cell biochemistry and function.

[33]  James D. Griffin,et al.  p130CAS Forms a Signaling Complex with the Adapter Protein CRKL in Hematopoietic Cells Transformed by the BCR/ABL Oncogene* , 1996, The Journal of Biological Chemistry.

[34]  L. Pilarski,et al.  The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. , 1996, Cancer research.

[35]  J. Taylor‐Papadimitriou,et al.  The Epithelial Mucin MUC1 Contains at Least Two Discrete Signals Specifying Membrane Localization in Cells (*) , 1996, The Journal of Biological Chemistry.

[36]  J. Wesseling,et al.  Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas. , 1995, Biochemical Society transactions.

[37]  D. Kufe,et al.  Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. , 1995, Cancer research.

[38]  J. Parsons,et al.  pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk , 1995, Molecular and cellular biology.

[39]  O. Elroy-Stein,et al.  Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins Cytokine receptor‐like molecules , 1994, FEBS letters.

[40]  H. Varmus,et al.  Association of the amino‐terminal half of c‐Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. , 1994, The EMBO journal.

[41]  T. Duhig,et al.  Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development. , 1992, Development.

[42]  J. Chow,et al.  MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1 , 2005, Clinical & Experimental Metastasis.

[43]  K. Pienta,et al.  Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endothelium , 2004, Clinical & Experimental Metastasis.

[44]  F. Luscinskas,et al.  Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. , 1996, Annual review of medicine.

[45]  J. Schlom,et al.  Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. , 1984, Hybridoma.